96 related articles for article (PubMed ID: 15319546)
1. Platinum complex cytotoxicity tested by the electrical resistance breakdown assay.
Ludwig T; Fakih S; Krebs B; Oberleithner H
Cell Physiol Biochem; 2004; 14(4-6):425-30. PubMed ID: 15319546
[TBL] [Abstract][Full Text] [Related]
2. New imidazole-coordinated chemotherapeutics with low epithelial toxicity.
Ludwig T; Fakih S; Bertram H; Krebs B; Oberleithner H
Cell Biochem Biophys; 2006; 45(1):31-41. PubMed ID: 16679562
[TBL] [Abstract][Full Text] [Related]
3. Platinum complex toxicity in cultured renal epithelia.
Ludwig T; Oberleithner H
Cell Physiol Biochem; 2004; 14(4-6):431-40. PubMed ID: 15319547
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of head and neck squamous cell carcinoma invasiveness by the electrical resistance breakdown assay.
Mandic R; Ludwig T; Oberleithner H; Werner JA
Clin Exp Metastasis; 2004; 21(8):699-704. PubMed ID: 16035614
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport.
Ludwig T; Riethmüller C; Gekle M; Schwerdt G; Oberleithner H
Kidney Int; 2004 Jul; 66(1):196-202. PubMed ID: 15200426
[TBL] [Abstract][Full Text] [Related]
6. The electrical resistance breakdown assay determines the role of proteinases in tumor cell invasion.
Ludwig T; Ossig R; Graessel S; Wilhelmi M; Oberleithner H; Schneider SW
Am J Physiol Renal Physiol; 2002 Aug; 283(2):F319-27. PubMed ID: 12110516
[TBL] [Abstract][Full Text] [Related]
7. High-resistance MDCK-C7 monolayers used for measuring invasive potency of tumour cells.
Zak J; Schneider SW; Eue I; Ludwig T; Oberleithner H
Pflugers Arch; 2000 May; 440(1):179-83. PubMed ID: 10864013
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a matrix-associated transepithelial resistance invasion assay to precisely measure the invasive potential of synovial fibroblasts.
Wunrau C; Schnaeker EM; Freyth K; Pundt N; Wendholt D; Neugebauer K; Hansen U; Pap T; Dankbar B
Arthritis Rheum; 2009 Sep; 60(9):2606-11. PubMed ID: 19714628
[TBL] [Abstract][Full Text] [Related]
9. Functional measurement of local proteolytic activity in living cells of invasive and non-invasive tumors.
Ludwig T; Püttmann S; Bertram H; Tatenhorst L; Paulus W; Oberleithner H; Senner V
J Cell Physiol; 2005 Mar; 202(3):690-7. PubMed ID: 15389570
[TBL] [Abstract][Full Text] [Related]
10. Use of cellular electrical impedance sensing to assess in vitro cytotoxicity of anticancer drugs in a human kidney cell nephrotoxicity model.
Xie F; Xu Y; Wang L; Mitchelson K; Xing W; Cheng J
Analyst; 2012 Mar; 137(6):1343-50. PubMed ID: 22214987
[TBL] [Abstract][Full Text] [Related]
11. Nanocapsules of platinum anticancer drugs: development towards therapeutic use.
Bryde S; de Kroon AI
Future Med Chem; 2009 Nov; 1(8):1467-80. PubMed ID: 21426060
[TBL] [Abstract][Full Text] [Related]
12. Assessing the invasive potential of bladder cancer: development and validation of a new preclinical assay.
Bolenz C; Gorzelanny C; Knauf D; Keil T; Steidler A; Halter N; Martini T; Schneider SW
J Urol; 2013 May; 189(5):1939-44. PubMed ID: 23063805
[TBL] [Abstract][Full Text] [Related]
13. Effect of ABCG2 on cytotoxicity of platinum drugs: interference of EGFP.
Ceckova M; Vackova Z; Radilova H; Libra A; Buncek M; Staud F
Toxicol In Vitro; 2008 Dec; 22(8):1846-52. PubMed ID: 18801423
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
Viale M; Cafaggi S; Parodi B; Esposito M
Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
[TBL] [Abstract][Full Text] [Related]
15. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
16. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
17. Impedance studies of bio-behavior and chemosensitivity of cancer cells by micro-electrode arrays.
Liu Q; Yu J; Xiao L; Tang JC; Zhang Y; Wang P; Yang M
Biosens Bioelectron; 2009 Jan; 24(5):1305-10. PubMed ID: 18783935
[TBL] [Abstract][Full Text] [Related]
18. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
[TBL] [Abstract][Full Text] [Related]
19. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes.
Lin M; Wang X; Zhu J; Fan D; Zhang Y; Zhang J; Guo Z
Apoptosis; 2011 Mar; 16(3):288-300. PubMed ID: 21107699
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of platinum compounds on renal cellular respiration in mice.
Almarzooqi SS; Alfazari AS; Abdul-Kader HM; Saraswathiamma D; Albawardi AS; Souid AK
Int J Clin Exp Pathol; 2015; 8(1):81-95. PubMed ID: 25755695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
